H

Hualan Biological Bacterin Inc
SZSE:301207

Watchlist Manager
Hualan Biological Bacterin Inc
SZSE:301207
Watchlist
Price: 21.71 CNY -0.14%
Market Cap: 13B CNY
Section:
 

Relative Value

The Relative Value of one Hualan Biological Bacterin Inc stock under the Base Case scenario is hidden CNY. Compared to the current market price of 21.71 CNY, Hualan Biological Bacterin Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Hualan Biological Bacterin Inc Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

13.1
P/S
P/S
Price to Sales
13.1
vs History
8
vs Industry
54
Median 3Y
9.3
Median 5Y
9.1
Industry
7.9
Forward
7.1
More Details
185.2
P/E
P/E
Price to Earnings
185.2
vs History
2
vs Industry
7
Median 3Y
33.6
Median 5Y
30.7
Industry
24
Forward
20.1
More Details
43.6
P/OCF
P/OCF
Price to OCF
43.6
vs History
22
vs Industry
12
Median 3Y
25.8
Median 5Y
28.1
Industry
21.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
10
Median 3Y
18
Median 5Y
16
Industry
23.7
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
52
vs Industry
46
Median 3Y
2.2
Median 5Y
2.3
Industry
3.4
More Details
10
EV/S
EV/S
Enterprise Value to Sales
10
vs History
10
vs Industry
49
Median 3Y
7.3
Median 5Y
6.8
Industry
8.3
Forward
5.4
More Details
13
EV/GP
EV/GP
Enterprise Value to Gross Profit
13
vs History
8
vs Industry
50
Median 3Y
9.1
Median 5Y
8.9
Industry
10.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
8
Median 3Y
27.3
Median 5Y
23.6
Industry
6.7
Forward
10.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
7
Median 3Y
27.3
Median 5Y
23.6
Industry
7.2
Forward
13.3
More Details
33.3
EV/OCF
EV/OCF
Enterprise Value to OCF
33.3
vs History
27
vs Industry
12
Median 3Y
21.9
Median 5Y
23.9
Industry
8.2
More Details
35.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
35.4
vs History
14
vs Industry
9
Median 3Y
22.7
Median 5Y
18
Industry
6.7
More Details
2.7
EV/IC
EV/IC
Enterprise Value to IC
2.7
vs History
45
vs Industry
50
Median 3Y
2.5
Median 5Y
2.7
Industry
5.7
More Details

Multiples Across Competitors

Competitors Multiples
Hualan Biological Bacterin Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hualan Biological Bacterin Inc
SZSE:301207
13B CNY 13.1 185.2 -342.1 -342.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 071 784.8 -161 938.1 -196 644.6 -194 400.6
US
Abbvie Inc
NYSE:ABBV
399.6B USD 6.7 170.2 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
177.5B USD 4.9 25.3 18.3 18.3
US
Gilead Sciences Inc
NASDAQ:GILD
150.6B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.7B USD 9.9 31.5 23.1 24.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.7 -527.6 -574.5 -559.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
75.6B USD 5.3 16.5 15.7 17.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
60.4B USD 18.8 1 385.9 182.8 221.7
AU
CSL Ltd
ASX:CSL
89.1B AUD 3.8 19.7 13.2 16.5
NL
argenx SE
XBRU:ARGX
47.2B EUR 15.2 35.8 62 63.7
P/E Multiple
Earnings Growth PEG
CN
H
Hualan Biological Bacterin Inc
SZSE:301207
Average P/E: 209.9
185.2
74%
2.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 938.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.2
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.5
9%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 385.9
N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
11%
1.8
NL
argenx SE
XBRU:ARGX
35.8
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
H
Hualan Biological Bacterin Inc
SZSE:301207
Average EV/EBITDA: 43
Negative Multiple: -342.1
111%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 644.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
182.8
N/A N/A
AU
CSL Ltd
ASX:CSL
13.2
8%
1.7
NL
argenx SE
XBRU:ARGX
62
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
H
Hualan Biological Bacterin Inc
SZSE:301207
Average EV/EBIT: 49.7
Negative Multiple: -342.1 		N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 400.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.3
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
13%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
221.7
N/A N/A
AU
CSL Ltd
ASX:CSL
16.5
11%
1.5
NL
argenx SE
XBRU:ARGX
63.7
N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.